Position in DYN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,655,719
-$857,579 QoQ
Shares Held
164,598
-33.9% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 245 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,026 across 296 Biotechnology names. DYN ranks #93 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in DYN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,655,719 | 164,598 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,513,298 | 248,941 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,693,097 | 137,684 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,487,170 | 117,563 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $781,990 | 82,142 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $693,423 | 66,293 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $950,008 | 40,323 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,523,797 | 42,422 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $9,170,246 | 259,854 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $7,098,635 | 250,040 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $999,786 | 75,172 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $845,778 | 94,395 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $776,710 | 69,041 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,775,097 | 240,894 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,562,076 | 134,778 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,749,258 | 137,737 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $77,946 | 11,346 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $112,767 | 11,698 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $135,616 | 11,406 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $187,425 | 11,541 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $209,430 | 9,954 | Shares | Defined | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||